πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 783 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7198947

Production of functional proteins: balance of shear stress and gravity

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration Β· Granted Tue Apr 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7179217

Apparatus for enhancing tissue repair in mammals

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration Β· Granted Tue Feb 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7175981

Method of diagnosing stage or aggressiveness of breast and prostate cancer based on levels

The United States of America as represented by the Secretary of the Army Β· Granted Tue Feb 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7175845

Monoclonal antibodies against ricin toxin and methods of making and using thereof

The United States of America as represented by the Secretary of the Army Β· Granted Tue Feb 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7173007

Therapy for microbial infections

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7151087

CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection

The United States of America as represented by the Department of Health and Human Resources Β· Granted Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7150875

Recombinant Plasmodium vivax merozoite protein-1 p42 vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7125553

Methods of inducing immune tolerance using immunotoxins

The United States of America as represented by the Department of Health and Human Services c/o Centers for Disease Control and Prevention Β· Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7118758

Transformed bacteria producing CS6 antigens as vaccines

The United States of America as represented by the Secretary of the Army Β· Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7112332

Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysac

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7109245

Vasoconstrictor cannabinoid analogs

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7105643

Monoclonal antibodies specific for crack cocaine metabolites, a cell line producing the sa

The United States of America as represented by the Attorney General of the Dept. of Justice Β· Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7101547

Method for the prevention and treatment of diseases caused by an inflammatory response med

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7101541

Utilization of non-viral sequences for minus-strand DNA transfer and gene reconstitution

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7094883

Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7094406

Enterically transmitted non-A/non-B hepatitis viral agent and characteristic epitopes ther

The United States of America as represented by the Secretary of the Department of Health and Human Services and Genelabs Technologies, Inc. Β· Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7094405

Peptides which elicit a high neutralizing antibody titer, cytotoxic T lymphocyte response

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7094045

Microencapsulation system and method

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration Β· Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7090852

Venezuelan equine encephalitis virus replicon encoding marburg virus proteins

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 15 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7084132

Artemisinins with improved stability and bioavailability for therapeutic drug development

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7081529

Recombinant vaccine against botulinum neurotoxin

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jul 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7067635

Nucleotide and deduced amino acid sequences of tumor gene Int6

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7060276

Plasmodium falciparum AMA-1 protein and uses thereof

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7052904

Hybrid adeno-retroviral vector for the transfection of cells

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 30 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted